The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-β type II receptor gene transfer

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 1 51-1, 2005, Pages

  Motomura, Y ^a   Kanbayashi, H ^a   Khan, W I ^a   Deng, Y ^a   Blennerhassett, P A ^a   Margetts, P J ^b   Gauldie, J ^b   Egashira, K ^c   Collins, S M ^a,d  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Adhesion; Anti inflammatory cytokine; Inflammation; Monocyte chemoattractant protein 1; Placental growth factor

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN; GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACENTAL GROWTH FACTOR; SERUM AMYLOID P; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROSIS; GENE THERAPY; GENE TRANSFER; INFLAMMATION; MALE; MESENTERY; MOUSE; NONHUMAN; PERITONEAL FIBROSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STORAGE; UPREGULATION; WEIGHT REDUCTION;

ANIMALS; CHEMOKINE CCL2; FIBROSIS; GENE TRANSFER TECHNIQUES; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED C57BL; PERITONEUM; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 10844228359     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00186.2004     Document Type: Article

References (54)

1. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, and Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343, 1996.
2. Beddy D, Watson RW, Fitzpatrick JM, and O'Connell PR. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease. Br J Surg 91: 72-77, 2004.
3. Benckert C, Jonas S, Cramer T, von Marschall Z, Schäfer G, Peters M, Wagner K, Radke C, Wiedenmann B, Neuhaus P, Höcker M, and Rosewicz S. Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 63: 1083-1092, 2003.
4. Bett AJ, Haddara W, Prevac L, and Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 2. Proc Natl Acad Sci USA 91: 8802-8806, 1994.
5. Bogdan C, Paik J, Vodovotz Y, and Nathan C. Contrasting mechanisms for suppression of macrophage cytokiné release by transforming growth factor-β and interleukin-10. J Biol Chem 267: 23301-23308, 1992.
6. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, Adnot S, and Maitre B. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 279: L371-L378, 2000.
7. Brogi E, Wu T, Namiki A, and Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649-652, 1994.
8. Carmeliet P, Moons L, Luttun A, Vincent V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, and Persico G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 1: 575-583, 2001.
9. Chua CC, Hamdy RC, and Chua BHL. Mechanism of transforming growth factor-β1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 1497: 69-76, 2000.
10. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, and Thomas KA. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87: 1323-1327, 1990.
11. Gary Lee YC, Melkerneker D, Thompson PJ, Light RW, and Lane KB. Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am J Respir Crit Care Med 165: 88-94, 2002.
12. Hahm KB, Im YH, Parks TW, Park SH, Markowitz S, Jung HY, Green J, and Kim SJ. Loss of transforming growth factor β signaling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 49: 190-198, 2001.
13. Karges WJ, Gaedigk R, and Bosch HM. Quantitative analysis of gene expression in different tissues by template-calibrated RT-PCR and laser-induced fluorescence PCR. Methods Appl 4: 154-159, 1994.
14. Kendall RL, Wang G, and Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226: 324-328, 1996.
15. Khan WI, Blennerhassett PA, Deng Y, Gauldie J, Vallance BA, and Collins SM. IL-12 gene transfer alters gut physiology and host immunity in nematode-infected mice. Am J Physiol Gastrointest Liver Physiol 281: 0102-0110, 2001.
16. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, and Koh GY. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kB activation in endothelial cells. J Biol Chem 276: 7614-7620, 2001.
17. Kondo K, Hiratsuka S, Subbalakshmi E, Matsushime H, and Shibuya M. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and 5-Ig tyrosine kinase receptors. Gene 208: 297-305, 1998.
18. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, and Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770-774, 1993.
19. Kuo CJ, Farnebo F, Yu EY, Christofferson R, Swearingen RA, Carter R, von Recum HA, Yuan J, Kamihara J, Flynn E, D'Amato R, Tolkman J, and Mulligan RC. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci USA 98: 4605-4610, 2001.
20. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, and Imaizumi T. Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106: 130-135, 2002.
21. Ling H, Li X, Jha S, Wang W, Karetskaya L, Pratt B, and Ledbetter S. Therapeutic role of TGF-β-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J Am Soc Nephrol 14: 377-388, 2003.
22. Lucas PA, Warejcka DJ, Young HE, and Lee BY. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-β1. J Surg Res 65: 135-138, 1996.
23. Luttun A, Tjwa M, Carmeliet P. Placental growth factor (P1GF) and its receptor Fit-1 (VEGFR-1). Ann NY Acad Sci 979: 80-93, 2002.
24. Lutton A, Tjwa M, Moons JL, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, and Carmeliet P. Revascularization of ischemic tissues by P1GF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Fit-1. Nat Med 8: 831-840, 2002.
25. Maglione D, Cuerriero V, Vigliette G, Delli-Bovi P, and Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271, 1991.
26. Manthey CL, Allen JB, Ellingswirth LR, and Wahl SM. In situ expression of transforming growth factor β in streptococcal cell wall-induced granulomatous inflammation and hepatic fibrosis. Growth Factors 4:17-26, 1990.
27. Margetts PJ, KoIb M, Galt T, Hoff CM, Shockley TR, and Gauldie J. Gene transfer of transforming growth factor-β1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 12: 2029-2039, 2001.
28. Marumo T, Schini-Kerth VB, and Busse R. Vascular endothelial growth factor activates nuclear factor-κB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48: 1131-1137, 1999.
29. McCormick LL, Zhang Y, Tootell E, and Gilliam AC. Anti-TGF-β treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 163: 5693-5699, 1999.
30. Miotla J, Maciewicz R, Kendrew J, Feldmann M, and Paleolog E. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 80: 1195-1205, 2000.
31. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, and Deuel TF. Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science 237: 1333-1336, 1987.
32. Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, and Miyazono K. Targets of transcriptional regulation by two distinct type 1 receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J Cell Physiol 193: 299-318, 2002.
33. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, and Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269: 6271-6274, 1994.
34. Plouet J, Schilling J, and Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 8: 3801-3806, 1989.
35. Qi Z, Atsuchi N, Ooshima A, Takeshita A, and Ueno H. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 96: 2345-2349, 1999.
36. Reddy GK and Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29: 225-229, 1996.
37. Rollins BJ, Morrison ED, and Stiles CD. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA 85: 3738-3742, 1988.
38. Saadeh PB, Mehrara BJ, Steinbrech DS, Dudziak ME, Greenwald JA, Luchs JS, Spector JA, Ueno H, Gittes GK, and Longaker MT. Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol Cell Physiol 277: C628-C637, 1999.
39. Sakamoto T, Ueno H, Sonoda K, Hisatomi T, Shimizu K, Ohashi H, and Inomata H. Blockade of TGF-β by in vivo gene transfer of a soluble TGF-β type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Ther 7: 1915-1924, 2000.
40. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzei G, Calvin D, Annunziata N, and Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992.
41. Sime PJ, Xing Z, Graham FL, Casky KG, and Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776, 1997.
42. Szalai AJ, Van Ginkel FW, Dalrymple SA, Murray R, McGhee JR, and Volonakis JE. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 160: 5294-5299, 1998.
43. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, and Feldman M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor- β. Eur J Immunol 21: 1635-1639, 1991.
44. Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita A, Shimizu K, and Ohashi H. A soluble transforming growth factor β receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 11: 33-42, 2000.
45. Verdu EF, Deng Y, Bercik P, and Collins SM. Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol 283: G27-G36, 2002.
46. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, and Sporn MB. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 84: 5788-5792, 1987.
47. Wahl SM, Hunt DA, Wong HL, Doughery S, McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA, Hall G, Roberts AB, and Sporn MB. Transforming growth factor- β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 140: 3026-3032, 1988.
48. Wiseman DM, Polverini PJ, Kamp DW, and Leibovich SJ. Transforming growth factor-beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157: 793-800, 1988.
49. Xing Z, Ohkawara Y, Jordana M, Graham FL, and Gauldie J. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J Clin Invest 97: 1102-1110, 1996.
50. Yamamoto T, Eckes B, Mauch C, Hartmann K, and Krieg T. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1a loop. J Immunol 164: 6174-6179, 2000.
51. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Wu Y, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Masaki T, and Fukui H. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52: 1347-1354, 2003.
52. Zhao Q, Egashira K, Inoue S, Usui M, Kitamoto S, Ni W, Ishibashi M, Hiasa K, Ichiki T, Shibuya M, and Takeshita A. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 105: 1110-1115, 2002.
53. Zheng H, Wang J, Koteliansky VE, Gotwals PJ, and Hauer-Jensen M. Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice. Castroenterology 119: 1286-1296, 2000.
54. Zhou A, Ueno H, Shimomura M, Tanaka R, Shirakawa T, Nakamura H, Matsuo M, and Iijima K. Blockade of TGF-β action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. Kidney Int 64:92-101, 2003.